The effects of a novel cyclohexane dicarboximide derivative, ST-6, on hypoxia/reoxygenation injury in perfused rat heart

Biological and Pharmaceutical Bulletin

Volumn 23, Issue 6, 2000, Pages 712-716

  Takeo, Satoshi ^a   Tanonaka, Kouichi ^a   Kajiwara, Hiroshi ^a   Miyake, Keiko ^a   Antoku, Fujio ^b   Mori, Hideki ^c  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^c FUKUYAMA UNIVERSITY   (Japan)

Author keywords

Cardioprotection; Heart; Hypoxia; Reoxygenation; Sodium channel blockade; Sodium overload

Indexed keywords

2 [4 [4 (4 CHLOROPHENYL) 4 HYDROXY 1 PIPERIDINYL]BUTYL]HEXAHYDRO 1H ISOINDOL 1,3 DIONE; CREATINE KINASE; CYCLOHEXANE DERIVATIVE; POTASSIUM ION; PURINE NUCLEOSIDE; SODIUM ION; ST 6; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; RAT; REOXYGENATION; REPERFUSION INJURY; SODIUM TRANSPORT;

EID: 0033935878     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.23.712     Document Type: Article

References (23)

1. Tani M., Neely J. R., Circ. Res., 65, 1045-1056 (1989).
2. Shen A. C., Jennings R. B., Am. J. Pathol., 67, 441-452 (1972).
3. Kloner R. A., Ganote C. E., Jennings R. B., J. Clin. Invent., 54, 1496-1508 (1974),
4. Zweier J. L., Flaherty J. T., Weusfeldt M. L., Proc. Natl. Acad. Sci. U.S.A., 84, 1404-1407 (1987).
5. Ganote C. E., Kaltenbach J. P., J. Mol. Cell. Cardiol., 11, 389-406 (1979).
6. Liu J.-X., Tanonaka K., Sanbe A., Yamamoto K., Takeo S., J. Mol. Cell. Cardiol., 25, 1249-1263 (1993).
7. Liu J.-X., Tanonaka K., Ohtsuka T., Sakai Y., Takeo S., J. Pharmacol. Exp. Ther., 266, 1247-1254 (1993).
8. Kamiyama T., Tanonaka K., Harada H., Nakai K., Takeo S., Eur. J. Pharmacol., 272, 151-158 (1995).
9. Takeo S., Tanonaka K., Hayashi M., Yamamoto K., Liu J.-X., Kamiyama T., Yamaguchi N., Miura A., Natsukawa T., J. Pharmacol. Exp. Ther., 273, 1403-1409 (1995).
10. Catterall W., Mackies K., "Goodman and Gilman's; The Pharmacological Basis of Therapeutics," 9th ed., ed. by Hardman J. G., Limbird J. E., McGraw-Hill, New York, 1996, pp. 331-347.
11. Takeo S., Hayashi M., Tanonaka K., Yamamoto K., J. Pharmacol. Exp. Ther., 258: 94-102 (1991).
12. Fujioka H., Yoshihara S., Tanaka T., Fukumoto T., Kuroiwa A., Tononaka K., Hayashi M., Takeo S., J. Mol. Cell. Cardiol., 23, 949-962 (1991).
13. Takeo S., Antoku F., Japanese Patent Publication (Kokai) H04-308569, (1993).
14. Bergmeyer H. U., Rich W., Butter H., Schmidt E., Hillman G., Kreu F. H., Stamm D., Lang H., Szasz G., Laue D., Z. Klin. Chem. Biochim., 8, 658-660 (1970).
15. Tanonaka K., Kajiwara H., Kameda H., Takasaki A., Takeo S., Eur. J. Pharmacol., 372, 37-48 (1999).
16. Kamiyama T., Tanonaka K., Hayashi J., Takeo S., Jpn. J. Pharmacol., 70, 227-234 (1996).
17. Meng H.-P., Lonsberry B. B., Pierce G. N., J. Pharmacol. Exp. Ther., 258, 772-777 (1991).
18. Pierce G. N., Czubryt M. P., J. Mol. Cell. Cardiol., 27, 53-63 (1995).
19. Ver Donck L., Borgers M., Ver Donck F., Cardiovasc. Res., 27, 349-357 (1993).
20. Silverman H. S., Stern M. D., Cardiovasc. Res., 28, 581-597 (1994).
21. Takeo S., Tanonaka K., Miyake K., Fukumoto T., Can. J. Cardiol. 4, 193-200 (1988).
22. Takeo S., Yamada H., Tanonaka K., Hayashi M., Sunagawa N., J. Pharmacol. Exp Ther., 254: 847-856 (1990).
23. Tanonaka K., Niwa T., Takeo S., Jpn. Heart J., 37, 105-117 (1996).